Dr. Patierno's current translational research interests are focused on the genomics molecular biology of cancer disparities, cancer biology, molecular pharmacology and targeted experimental therapeutics to control prostate, breast and lung tumor aggressiveness. He is an internationally recognized expert in cancer control, cancer causation and molecular carcinogenesis, which includes a broad spectrum of laboratory and population level research. He is also actively engaged in cancer health disparities and healthcare delivery research focused on patient navigation, survivorship, community-based interventions, mHealth, implementation sciences, cancer care economics, and policy.
Shah A, Polascik TJ, George DJ, Anderson J, Hyslop T, Ellis AM, et al. Implementation and Impact of a Risk-Stratified Prostate Cancer Screening Algorithm as a Clinical Decision Support Tool in a Primary Care Network. In: Journal of General Internal Medicine. 2020.
Crankshaw S, Butt J, Gierisch JM, Barrett NJ, Mervin-Blake S, Oeffinger K, et al. The Durham Initiative for Stomach Health (DISH): a pilot community-based Helicobacter pylori education and screening study. Bmc Gastroenterol. 2020 Aug 6;20(1):261.
Corbett CM, Somers TJ, Nuñez CM, Majestic CM, Shelby RA, Worthy VC, et al. Evolution of a longitudinal, multidisciplinary, and scalable patient navigation matrix model. Cancer Med. 2020 May;9(9):3202–10.